Sarepta Therapeutics - 22 Year Stock Price History | SRPT

Historical daily share price chart and data for Sarepta Therapeutics since 1997 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Sarepta Therapeutics as of February 15, 2019 is 138.45.
Sarepta Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 124.5997 107.5000 141.7100 106.6700 138.4500 26.87%
2018 105.9535 58.2500 161.5100 54.0200 109.1300 96.14%
2017 39.1454 27.9200 56.7500 27.6700 55.6400 102.84%
2016 26.6381 38.0700 62.3500 10.7400 27.4300 -28.90%
2015 25.1902 14.9400 41.7900 11.6100 38.5800 166.62%
2014 24.1064 20.5800 38.9100 12.6000 14.4700 -28.96%
2013 33.2875 26.2400 53.8100 12.8900 20.3700 -21.05%
2012 11.8641 4.4400 44.9300 3.4600 25.8000 477.18%
2011 8.6942 13.0200 15.4800 3.2400 4.4700 -64.86%
2010 10.0156 9.4800 13.0800 6.9000 12.7200 45.21%
2009 8.0035 4.0800 14.8200 3.3006 8.7600 121.88%
2008 7.1255 8.5200 11.2800 2.8800 3.9480 -53.33%
2007 16.1696 18.5400 19.2000 7.8600 8.4600 -55.66%
2006 28.7698 20.3400 51.9000 15.4800 19.0800 -7.83%
2005 15.9895 13.5000 24.8405 12.0000 20.7000 46.81%
2004 16.0193 24.4800 28.5000 9.5400 14.1000 -42.26%
2003 29.1052 29.2200 42.3000 12.2400 24.4200 -18.60%
2002 37.5316 66.2400 77.8200 16.1940 30.0000 -54.21%
2001 44.1418 25.8780 67.1400 18.0000 65.5200 129.89%
2000 61.9330 34.5000 157.1400 24.3780 28.5000 -12.65%
1999 23.7957 24.3780 43.5000 15.3780 32.6280 35.95%
1998 32.6481 40.8780 45.9360 16.5000 24.0000 -41.82%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $9.252B $0.155B
Sarepta Therapeutics, Inc. focuses on the discovery and development of RNA-based therapeutics for the treatment of rare and infectious diseases. The Company's diverse pipeline includes its lead program eteplirsen, for Duchenne muscular dystrophy. Sarepta Therapeutics, Inc., formerly known as AVI BioPharma, Inc., is headquartered in Bothell, Washington.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $117.200B 13.07
Gilead Sciences (GILD) United States $87.436B 10.97
Biogen (BIIB) United States $65.479B 12.69
Celgene (CELG) United States $63.576B 11.78
Vertex Pharmaceuticals (VRTX) United States $48.081B 64.41
Regeneron Pharmaceuticals (REGN) United States $46.330B 21.52
Illumina (ILMN) United States $44.074B 52.42
Alexion Pharmaceuticals (ALXN) United States $28.921B 17.93
Incyte (INCY) United States $17.908B 168.30
BioMarin Pharmaceutical (BMRN) United States $16.736B 0.00
Seattle Genetics (SGEN) United States $11.477B 0.00
Exact Sciences (EXAS) United States $10.883B 0.00
QIAGEN (QGEN) Netherlands $8.819B 28.84
Alnylam Pharmaceuticals (ALNY) United States $8.451B 0.00
BeiGene (BGNE) Cayman Islands $7.856B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.748B 49.54
Bluebird Bio (BLUE) United States $7.495B 0.00
Bio-Techne Corp (TECH) United States $7.237B 48.76
Moderna (MRNA) United States $7.053B 0.00
Exelixis (EXEL) United States $6.655B 15.57
Amarin (AMRN) Ireland $5.703B 0.00
Galapagos (GLPG) Belgium $5.283B 0.00
Alkermes (ALKS) Ireland $5.056B 0.00
Array BioPharma (ARRY) United States $5.047B 0.00
Guardant Health (GH) United States $4.379B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.077B 0.00
Horizon Pharma Public (HZNP) Ireland $3.884B 15.98
Allogene Therapeutics (ALLO) United States $3.795B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.458B 0.00
Emergent Biosolutions (EBS) United States $3.371B 28.39
Blueprint Medicines (BPMC) United States $3.339B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.286B 0.00
Ascendis Pharma (ASND) Denmark $3.087B 0.00
Genomic Health (GHDX) United States $3.010B 101.63
ACADIA Pharmaceuticals (ACAD) United States $2.908B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.865B 0.00
Global Blood Therapeutics (GBT) United States $2.722B 0.00
Immunomedics (IMMU) United States $2.710B 0.00
China Biologic Products (CBPO) China $2.701B 19.23
Repligen (RGEN) United States $2.640B 82.45
Ligand Pharmaceuticals (LGND) United States $2.569B 18.45
Reata Pharmaceuticals (RETA) United States $2.566B 0.00
Mirati Therapeutics (MRTX) United States $2.496B 0.00
Akcea Therapeutics (AKCA) United States $2.472B 0.00
Arena Pharmaceuticals (ARNA) United States $2.466B 0.00
Halozyme Therapeutics (HALO) United States $2.463B 54.97
Myriad Genetics (MYGN) United States $2.305B 23.48
Amicus Therapeutics (FOLD) United States $2.162B 0.00
Insmed (INSM) United States $2.087B 0.00
Spark Therapeutics (ONCE) United States $1.992B 0.00
Denali Therapeutics (DNLI) United States $1.991B 0.00
Acceleron Pharma (XLRN) United States $1.961B 0.00
Atara Biotherapeutics (ATRA) United States $1.846B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.830B 0.00
Medicines (MDCO) United States $1.830B 0.00
AnaptysBio (ANAB) United States $1.829B 0.00
REGENXBIO (RGNX) United States $1.725B 23.14
MyoKardia (MYOK) United States $1.719B 0.00
NeoGenomics (NEO) United States $1.649B 135.69
CRISPR Therapeutics AG (CRSP) Switzerland $1.636B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.630B 0.00
Myovant Sciences (MYOV) United Kingdom $1.509B 0.00
Innoviva (INVA) United States $1.497B 4.13
Allakos (ALLK) United States $1.468B 0.00
Aimmune Therapeutics (AIMT) United States $1.422B 0.00
UniQure (QURE) Netherlands $1.396B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.380B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.347B 0.00
Clovis Oncology (CLVS) United States $1.344B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.282B 0.00
Lion Biotechnologies (IOVA) United States $1.272B 0.00
Cambrex (CBM) United States $1.265B 13.65
Codexis (CDXS) United States $1.184B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.172B 0.00
WAVE Life Sciences (WVE) Singapore $1.108B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.107B 44.91
Rubius Therapeutics (RUBY) United States $1.104B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.092B 0.00
Audentes Therapeutics (BOLD) United States $1.055B 0.00
Puma Biotechnology (PBYI) United States $1.055B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.034B 0.00
Epizyme (EPZM) United States $1.020B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.978B 0.00
Editas Medicine (EDIT) United States $0.960B 0.00
Fate Therapeutics (FATE) United States $0.960B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.958B 0.00
Coherus BioSciences (CHRS) United States $0.948B 0.00
Sangamo Therapeutics (SGMO) United States $0.897B 0.00
Retrophin (RTRX) United States $0.889B 0.00
Athenex (ATNX) United States $0.846B 0.00
Vericel (VCEL) United States $0.845B 0.00
CytomX Therapeutics (CTMX) United States $0.829B 0.00
Novavax (NVAX) United States $0.815B 0.00
G1 THERAPEUTICS (GTHX) United States $0.781B 0.00
Apellis Pharmaceuticals (APLS) United States $0.778B 0.00
InflaRx (IFRX) Germany $0.777B 0.00
Arvinas (ARVN) United States $0.770B 0.00
Intra-Cellular Therapies (ITCI) United States $0.765B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.761B 0.00
Heska (HSKA) United States $0.743B 60.84
Cellectis (CLLS) France $0.726B 0.00
Principia Biopharma (PRNB) United States $0.723B 0.00
ANI Pharmaceuticals (ANIP) United States $0.722B 13.81
Dicerna Pharmaceuticals (DRNA) United States $0.718B 0.00
Dynavax Technologies (DVAX) United States $0.698B 0.00
Acorda Therapeutics (ACOR) United States $0.680B 8.83
Cara Therapeutics (CARA) United States $0.670B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.662B 0.00
Revance Therapeutics (RVNC) United States $0.654B 0.00
RA PHARMCTL INC (RARX) United States $0.650B 0.00
Viking Therapeutics (VKTX) United States $0.648B 0.00
Twist Bioscience (TWST) United States $0.643B 0.00
Intellia Therapeutics (NTLA) United States $0.607B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.577B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.567B 0.00
UROGEN PHARMA (URGN) Israel $0.565B 0.00
Kura Oncology (KURA) United States $0.564B 0.00
Eidos Therapeutics (EIDX) United States $0.563B 0.00
Anika Therapeutics (ANIK) United States $0.562B 23.25
Osiris Therapeutics (OSIR) United States $0.550B 0.00
Synthorx (THOR) United States $0.546B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.542B 0.00
Arcus Biosciences (RCUS) United States $0.529B 0.00
Prothena (PRTA) Ireland $0.524B 0.00
Zymeworks (ZYME) Canada $0.502B 0.00
PDL BioPharma (PDLI) United States $0.486B 7.93
UNITY Biotechnology (UBX) $0.476B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.466B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.465B 0.00
Scholar Rock Holding (SRRK) United States $0.462B 0.00
ObsEva SA (OBSV) Switzerland $0.451B 0.00
DBV Technologies (DBVT) France $0.450B 0.00
Zealand Pharma (ZEAL) Denmark $0.450B 4.96
Senesco Technologies (ELOX) United States $0.446B 0.00
Replimune (REPL) United States $0.444B 0.00
Agenus (AGEN) United States $0.433B 0.00
Cytokineticsorporated (CYTK) United States $0.432B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.424B 0.00
Kezar Life Sciences (KZR) United States $0.420B 0.00
Five Prime Therapeutics (FPRX) United States $0.411B 0.00
OSMOTICA PHARM (OSMT) United States $0.406B 0.00
BeyondSpring (BYSI) United States $0.404B 0.00
Mesoblast (MESO) Australia $0.398B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.373B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.369B 0.00
Kindred Biosciences (KIN) United States $0.367B 0.00
Sinovac Biotech (SVA) China $0.367B 0.00
AVROBIO (AVRO) United States $0.367B 0.00
Stemline Therapeutics (STML) United States $0.365B 0.00
Cellular Biomedicine (CBMG) United States $0.360B 0.00
Inovio Pharmaceuticals (INO) United States $0.353B 0.00
MeiraGTx Holdings (MGTX) United States $0.350B 0.00
Gamida Cell (GMDA) Israel $0.339B 0.00
Gritstone Oncology (GRTS) United States $0.337B 0.00
Krystal Biotech (KRYS) United States $0.332B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.330B 0.00
BioDelivery Sciences (BDSI) United States $0.328B 0.00
MediciNova (MNOV) United States $0.322B 0.00
Aduro Biotech (ADRO) United States $0.322B 0.00
Abeona Therapeutics (ABEO) United States $0.318B 0.00
Albireo Pharma (ALBO) United States $0.316B 0.00
Urovant Sciences (UROV) United States $0.314B 0.00
XBiotech (XBIT) United States $0.310B 0.00
Constellation Pharmaceuticals (CNST) United States $0.308B 0.00
Magenta Therapeutics (MGTA) United States $0.306B 0.00
Evelo Biosciences (EVLO) United States $0.292B 0.00
Enochian BioSciences (ENOB) United States $0.287B 0.00
Sorrento Therapeutics (SRNE) United States $0.285B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.283B 0.00
Solid Biosciences (SLDB) United States $0.283B 0.00
Axsome Therapeutics (AXSM) United States $0.278B 0.00
Geron (GERN) United States $0.274B 0.00
Intec Pharma (NTEC) Israel $0.269B 0.00
AC Immune SA (ACIU) Switzerland $0.261B 0.00
Kadmon Holdings (KDMN) United States $0.259B 0.00
Merus (MRUS) Netherlands $0.258B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.254B 0.00
Kodiak Sciences (KOD) United States $0.252B 0.00
Seres Therapeutics (MCRB) United States $0.250B 0.00
Liquidia Technologies (LQDA) United States $0.247B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.247B 0.00
Kala Pharmaceuticals (KALA) United States $0.244B 0.00
Verastem (VSTM) United States $0.244B 0.00
Celcuity (CELC) United States $0.241B 0.00
Adverum Biotechnologies (ADVM) United States $0.240B 0.00
Synlogic (SYBX) United States $0.236B 0.00
Kamada (KMDA) Israel $0.236B 10.64
Paratek Pharmaceuticals (PRTK) United States $0.232B 0.00
MannKind (MNKD) United States $0.231B 0.00
Syros Pharmaceuticals (SYRS) United States $0.231B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.229B 0.00
Sutro Biopharma (STRO) United States $0.225B 0.00
ResTORbio (TORC) United States $0.225B 0.00
Strongbridge Biopharma (SBBP) United States $0.221B 0.00
TOCAGEN INC (TOCA) United States $0.219B 0.00
Athersys (ATHX) United States $0.217B 0.00
Arbutus Biopharma (ABUS) Canada $0.215B 0.00
LogicBio Therapeutics (LOGC) United States $0.209B 0.00
ChromaDex (CDXC) United States $0.208B 0.00
Cerecor (CERC) United States $0.207B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.204B 0.00
Celyad SA (CYAD) Belgium $0.201B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.200B 0.00
ADMA Biologics Inc (ADMA) United States $0.196B 0.00
Aptinyx (APTX) United States $0.189B 0.00
Compugen (CGEN) Israel $0.186B 0.00
Spero Therapeutics (SPRO) United States $0.182B 0.00
CorMedix Inc (CRMD) United States $0.178B 0.00
Protagonist Therapeutics (PTGX) United States $0.178B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.174B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.166B 0.00
Enzo Biochem (ENZ) United States $0.166B 0.00
Menlo Therapeutics (MNLO) United States $0.164B 0.00
Palatin Technologies (PTN) United States $0.160B 78.98
Syndax Pharmaceuticals (SNDX) United States $0.159B 0.00
VBI Vaccines (VBIV) United States $0.157B 0.00
Mersana Therapeutics (MRSN) United States $0.156B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.155B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.151B 0.00
Proteostasis Therapeutics (PTI) United States $0.149B 0.00
BioTime (BTX) United States $0.149B 0.00
OvaScience (MLND) United States $0.145B 0.00
Allena Pharmaceuticals (ALNA) United States $0.143B 0.00
Cohbar (CWBR) United States $0.137B 0.00
BioXcel Therapeutics (BTAI) United States $0.136B 0.00
Cue Biopharma (CUE) United States $0.134B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.133B 0.00
Unum Therapeutics (UMRX) United States $0.129B 0.00
Organovo Holdings (ONVO) United States $0.128B 0.00
Pfenex (PFNX) United States $0.127B 0.00
Trevena (TRVN) United States $0.127B 0.00
Fortress Biotech (FBIO) United States $0.124B 0.00
Mustang Bio (MBIO) United States $0.122B 0.00
Anavex Life Sciences (AVXL) United States $0.121B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.121B 0.00
Checkpoint Therapeutics (CKPT) United States $0.121B 0.00
Pluristem Therapeutics (PSTI) Israel $0.119B 0.00
Eton Pharmaceuticals (ETON) United States $0.119B 0.00
XOMA (XOMA) United States $0.118B 0.00
Equillium (EQ) United States $0.113B 0.00
Oncobiologics (OTLK) United States $0.112B 0.00
Catalyst Biosciences (CBIO) United States $0.107B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.102B 0.00
VolitionRX (VNRX) Singapore $0.102B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.100B 0.00
VTv Therapeutics (VTVT) United States $0.097B 0.00
Chiasma (CHMA) United States $0.095B 0.00
Neothetics (EVFM) United States $0.093B 0.00
Signal Genetics (MGEN) United States $0.091B 0.00
NantKwest (NK) United States $0.090B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.082B 0.00
Cel-Sci (CVM) United States $0.081B 0.00
Cocrystal Pharma (COCP) United States $0.079B 88.33
Merrimack Pharmaceuticals (MACK) United States $0.078B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.078B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.078B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.077B 0.00
Orgenesis (ORGS) United States $0.077B 0.00
Alimera Sciences (ALIM) United States $0.076B 0.00
Provention Bio (PRVB) United States $0.075B 0.00
PHASEBIO PHARMA (PHAS) United States $0.073B 0.00
Idera Pharmaceuticals (IDRA) United States $0.072B 0.00
Aptose Biosciences (APTO) Canada $0.072B 0.00
Cidara Therapeutics (CDTX) United States $0.070B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
Celldex Therapeutics (CLDX) United States $0.067B 0.00
Protalix BioTherapeutics (PLX) Israel $0.067B 0.00
SESEN BIO, INC (SESN) United States $0.065B 0.00
AEterna Zentaris (AEZS) United States $0.065B 12.28
Sienna Biopharmaceuticals (SNNA) United States $0.062B 0.00
OVID THERAPEUTC (OVID) United States $0.062B 0.00
Prima BioMed (IMMP) Australia $0.060B 0.00
Applied Genetic Technologies (AGTC) United States $0.059B 0.00
Evogene (EVGN) Israel $0.058B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.058B 0.00
Ophthotech (OPHT) United States $0.058B 0.00
Proteon Therapeutics (PRTO) United States $0.057B 0.00
NewLink Genetics (NLNK) United States $0.057B 0.00
Vaccinex (VCNX) United States $0.056B 0.00
Eyenovia (EYEN) United States $0.056B 0.00
Entera Bio (ENTX) Israel $0.054B 0.00
VIVUS (VVUS) United States $0.054B 0.00
ScPharmaceuticals (SCPH) United States $0.053B 0.00
ARAVIVE, INC (ARAV) United States $0.053B 4.67
Alcobra (ARCT) United States $0.053B 0.00
Clearside Biomedical (CLSD) United States $0.051B 0.00
Asterias Biotherapeutics (AST) United States $0.050B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
Bellerophon Therapeutics (BLPH) United States $0.048B 0.00
VistaGen Therapeutics (VTGN) United States $0.045B 0.00
Selecta Biosciences (SELB) United States $0.044B 0.00
Bionano Genomics (BNGO) United States $0.042B 0.00
Celsion (CLSN) United States $0.041B 0.00
Caladrius Biosciences (CLBS) United States $0.041B 0.00
OncoSec Medical (ONCS) United States $0.041B 0.00
Moleculin Biotech (MBRX) United States $0.040B 0.00
Motif Bio Plc (MTFB) United States $0.040B 0.00
Arsanis (ASNS) United States $0.039B 0.00
DiaMedica Therapeutics (DMAC) United States $0.038B 0.00
AquaBounty Technologies (AQB) United States $0.038B 0.00
Aptevo Therapeutics (APVO) United States $0.037B 0.00
Leap Therapeutics (LPTX) United States $0.035B 0.00
Oncolytics Biotech (ONCY) Canada $0.035B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.035B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.034B 5.58
Curis (CRIS) United States $0.034B 0.00
Sophiris Bio (SPHS) United States $0.033B 0.00
Galena Biopharma (SLS) United States $0.031B 0.00
AZURRX BIOPHARM (AZRX) United States $0.031B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.031B 0.00
Adial Pharmaceuticals (ADIL) United States $0.030B 0.00
TRACON Pharmaceuticals (TCON) United States $0.029B 0.00
Aileron Therapeutics (ALRN) United States $0.028B 0.00
IMMURON LTD (IMRN) Australia $0.028B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.028B 0.00
Oragenics (OGEN) United States $0.028B 0.00
Advaxis (ADXS) United States $0.028B 0.00
Zosano Pharma (ZSAN) United States $0.026B 0.00
Novelion Therapeutics (NVLN) Canada $0.025B 0.00
GENPREX INC (GNPX) United States $0.024B 0.00
Apricus Biosciences (SEEL) United States $0.023B 0.00
GTx (GTXI) United States $0.023B 0.00
Vical (VICL) United States $0.022B 0.00
BioPharmX (BPMX) United States $0.021B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.021B 0.00
CytRx (CYTR) United States $0.020B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.020B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.020B 0.00
Benitec Biopharma (BNTC) Australia $0.019B 0.00
IBio (IBIO) United States $0.016B 0.00
Gemphire Therapeutics (GEMP) United States $0.016B 0.00
Novogen (KZIA) Australia $0.016B 0.00
Cleveland BioLabs (CBLI) United States $0.016B 0.00
ATyr Pharma (LIFE) United States $0.015B 0.00
Soligenix (SNGX) United States $0.015B 0.00
Therapix Biosciences (TRPX) Israel $0.014B 7.25
Prana Biotechnology (PRAN) Australia $0.014B 0.00
Genetic Technologies (GENE) Australia $0.014B 0.00
Aytu Bioscience (AYTU) United States $0.013B 0.00
Edge Therapeutics (EDGE) United States $0.013B 0.00
TrovaGene (TROV) United States $0.012B 0.00
Hemispherx BioPharma (HEB) United States $0.011B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
Alliqua BioMedical (ALQA) United States $0.011B 0.00
Neuralstem (CUR) United States $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.010B 0.00
Vital Therapies (VTL) United States $0.009B 0.00
Dare Bioscience (DARE) United States $0.009B 0.00
Synthetic Biologics (SYN) United States $0.008B 0.00
RestorGenex (DFFN) United States $0.008B 0.00
AmpliPhi Biosciences (APHB) United States $0.008B 0.00
Histogenics (HSGX) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.007B 0.00
Pulmatrix (PULM) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cellect Biotechnology (APOP) Israel $0.006B 0.00
ARCA Biopharma (ABIO) United States $0.005B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.004B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Tenax Therapeutics (TENX) United States $0.002B 0.00